Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON ZYDUS LIFESCIENCES BIOCON /
ZYDUS LIFESCIENCES
 
P/E (TTM) x 19.7 34.2 57.5% View Chart
P/BV x 1.8 5.8 31.2% View Chart
Dividend Yield % 0.6 0.6 95.2%  

Financials

 BIOCON    ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    BIOCON
Mar-23
ZYDUS LIFESCIENCES
Mar-23
BIOCON /
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs388495 78.4%   
Low Rs192319 60.0%   
Sales per share (Unadj.) Rs93.1170.3 54.7%  
Earnings per share (Unadj.) Rs5.419.8 27.1%  
Cash flow per share (Unadj.) Rs14.626.9 54.3%  
Dividends per share (Unadj.) Rs1.506.00 25.0%  
Avg Dividend yield %0.51.5 35.1%  
Book value per share (Unadj.) Rs146.5173.0 84.7%  
Shares outstanding (eoy) m1,200.601,012.20 118.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.12.4 130.2%   
Avg P/E ratio x54.120.6 262.7%  
P/CF ratio (eoy) x19.815.1 130.9%  
Price / Book Value ratio x2.02.4 84.0%  
Dividend payout %28.030.3 92.3%   
Avg Mkt Cap Rs m347,814412,144 84.4%   
No. of employees `000NANA-   
Total wages/salary Rs m21,81024,564 88.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m111,742172,374 64.8%  
Other income Rs m7,6814,746 161.8%   
Total revenues Rs m119,423177,120 67.4%   
Gross profit Rs m16,61129,677 56.0%  
Depreciation Rs m11,1317,227 154.0%   
Interest Rs m4,1901,299 322.6%   
Profit before tax Rs m8,97125,897 34.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5415,878 43.2%   
Profit after tax Rs m6,43020,019 32.1%  
Gross profit margin %14.917.2 86.3%  
Effective tax rate %28.322.7 124.8%   
Net profit margin %5.811.6 49.5%  
BALANCE SHEET DATA
Current assets Rs m123,340100,082 123.2%   
Current liabilities Rs m85,10755,267 154.0%   
Net working cap to sales %34.226.0 131.6%  
Current ratio x1.41.8 80.0%  
Inventory Days Days12950 256.5%  
Debtors Days Days11794 124.8%  
Net fixed assets Rs m394,078144,776 272.2%   
Share capital Rs m6,0031,012 593.2%   
"Free" reserves Rs m169,926174,146 97.6%   
Net worth Rs m175,929175,158 100.4%   
Long term debt Rs m152,9050-   
Total assets Rs m517,418244,940 211.2%  
Interest coverage x3.120.9 15.0%   
Debt to equity ratio x0.90-  
Sales to assets ratio x0.20.7 30.7%   
Return on assets %2.18.7 23.6%  
Return on equity %3.711.4 32.0%  
Return on capital %4.015.5 25.8%  
Exports to sales %3.139.2 7.9%   
Imports to sales %6.011.9 50.0%   
Exports (fob) Rs m3,46767,577 5.1%   
Imports (cif) Rs m6,65420,544 32.4%   
Fx inflow Rs m3,46767,577 5.1%   
Fx outflow Rs m6,65420,544 32.4%   
Net fx Rs m-3,18747,033 -6.8%   
CASH FLOW
From Operations Rs m18,52526,888 68.9%  
From Investments Rs m-142,81811,712 -1,219.4%  
From Financial Activity Rs m130,487-44,004 -296.5%  
Net Cashflow Rs m6,411-5,338 -120.1%  

Share Holding

Indian Promoters % 40.4 75.0 53.8%  
Foreign collaborators % 20.3 0.0 -  
Indian inst/Mut Fund % 21.1 18.0 116.8%  
FIIs % 6.6 5.0 131.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 25.0 157.3%  
Shareholders   434,339 306,495 141.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    MANKIND PHARMA    


More on Biocon vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs Cadila Healthcare Share Price Performance

Period Biocon Cadila Healthcare S&P BSE HEALTHCARE
1-Day 2.92% 0.57% 1.18%
1-Month -2.53% 7.77% -0.75%
1-Year 30.52% 107.52% 61.82%
3-Year CAGR -13.55% 32.30% 18.16%
5-Year CAGR -2.73% 24.52% 19.79%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 28.0%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of Biocon, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.